These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

519 related items for PubMed ID: 11466176

  • 1. Stereospecific pharmacokinetics and pharmacodynamics of beta-adrenergic blockers in humans.
    Mehvar R, Brocks DR.
    J Pharm Pharm Sci; 2001; 4(2):185-200. PubMed ID: 11466176
    [Abstract] [Full Text] [Related]

  • 2. [Beta blockers in migraine prophylaxis].
    Shimizu T.
    Brain Nerve; 2009 Oct; 61(10):1125-30. PubMed ID: 19882938
    [Abstract] [Full Text] [Related]

  • 3. β-blockers: a review of their pharmacological and physiological diversity in hypertension.
    Ripley TL, Saseen JJ.
    Ann Pharmacother; 2014 Jun; 48(6):723-33. PubMed ID: 24687542
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Gender-related effects on metoprolol pharmacokinetics and pharmacodynamics in healthy volunteers.
    Luzier AB, Killian A, Wilton JH, Wilson MF, Forrest A, Kazierad DJ.
    Clin Pharmacol Ther; 1999 Dec; 66(6):594-601. PubMed ID: 10613615
    [Abstract] [Full Text] [Related]

  • 6. [Pharmacological basis for the therapy of cardiovascular disease with beta-adrenoceptor blocking drugs (author's transl)].
    Lemmer B.
    Herz; 1982 Jun; 7(3):168-78. PubMed ID: 6124492
    [Abstract] [Full Text] [Related]

  • 7. [Specific and nonspecific effects of beta receptor blockers: stereoselectively different properties exemplified by (R)- and (S)-propranolol].
    Stoschitzky K, Lindner W.
    Wien Med Wochenschr; 1990 Apr 15; 140(6-7):156-62. PubMed ID: 1971978
    [Abstract] [Full Text] [Related]

  • 8. Comparative review of beta-blocking agents.
    Jackson EA, Sullman SA.
    Conn Med; 1984 Apr 15; 48(4):213-5. PubMed ID: 6143648
    [No Abstract] [Full Text] [Related]

  • 9. The role of the new beta-blockers in treating cardiovascular disease.
    Weber MA.
    Am J Hypertens; 2005 Dec 15; 18(12 Pt 2):169S-176S. PubMed ID: 16373195
    [Abstract] [Full Text] [Related]

  • 10. [Characteristics of action of various drugs blocking atrioventricular conduction (beta-blockers, verapamil, diltiazem) in constant fibrillation tachyarrhythmia. Is monotherapy optimal?].
    Blagova OV, Nedostup AV.
    Ter Arkh; 2006 Dec 15; 78(8):30-8. PubMed ID: 17078214
    [Abstract] [Full Text] [Related]

  • 11. Effect of aging on the pharmcokinetics of atenolol, metoprolol and propranolol in the rat.
    Belpaire FM, de Smet F, Vynckier LJ, Vermeulen AM, Rosseel MT, Bogaert MG, Chauvelot-Moachon L.
    J Pharmacol Exp Ther; 1990 Jul 15; 254(1):116-22. PubMed ID: 2366179
    [Abstract] [Full Text] [Related]

  • 12. beta-Adrenoceptor antagonists: new drugs and new indications.
    Koch-Weser J, Frishman WH.
    N Engl J Med; 1981 Aug 27; 305(9):500-6. PubMed ID: 6114433
    [No Abstract] [Full Text] [Related]

  • 13. Pharmacokinetics of beta-adrenoceptor blocking agents: clinical significance of hepatic and/or renal clearance.
    Borchard U.
    Clin Physiol Biochem; 1990 Aug 27; 8 Suppl 2():28-34. PubMed ID: 1982759
    [Abstract] [Full Text] [Related]

  • 14. Comparative pharmacokinetics and pharmacodynamics of propranolol and atenolol in normolipaemic and hyperlipidaemic obese subjects.
    Wójcicki J, Jaroszynska M, Droździk M, Pawlik A, Gawrońska-Szklarz B, Sterna R.
    Biopharm Drug Dispos; 2003 Jul 27; 24(5):211-8. PubMed ID: 12784321
    [Abstract] [Full Text] [Related]

  • 15. Receptor binding characteristics and pharmacokinetic properties as a tool for the prediction of clinical effects of beta-blockers.
    Wellstein A, Palm D, Belz GG, Pitschner HF.
    Arzneimittelforschung; 1985 Jul 27; 35(1):2-6. PubMed ID: 2859024
    [Abstract] [Full Text] [Related]

  • 16. Beta-blockers in the treatment of hypertension: are there clinically relevant differences?
    Weir MR.
    Postgrad Med; 2009 May 27; 121(3):90-8. PubMed ID: 19491545
    [Abstract] [Full Text] [Related]

  • 17. Drug-drug interactions of beta-adrenoceptor blockers.
    Brodde OE, Kroemer HK.
    Arzneimittelforschung; 2003 May 27; 53(12):814-22. PubMed ID: 14732961
    [Abstract] [Full Text] [Related]

  • 18. Cardiac anti-ischemic effect of metoprolol: role of beta-blockade within the ischemic region.
    Ablad B, Abrahamsson T, Adler G, Björkman JA, Bjurö T, Ek L, Ervik M, Sjöquist PO, Sutherland I, Svensson L.
    J Cardiovasc Pharmacol; 1987 May 27; 10 Suppl 2():S117-25; discussion S126-7. PubMed ID: 2481161
    [Abstract] [Full Text] [Related]

  • 19. [Pharmacokinetic comparison of propranolol and atenolol in people with primary hypertension].
    Telatyńska-Smieszek B.
    Ann Acad Med Stetin; 2002 May 27; 48():367-80. PubMed ID: 14601489
    [Abstract] [Full Text] [Related]

  • 20. S-metoprolol: the 2008 clinical review.
    Dasbiswas A, Shinde S, Dasbiswas D.
    J Indian Med Assoc; 2008 Apr 27; 106(4):259-62. PubMed ID: 18828349
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 26.